Literature DB >> 12441396

Genomic analysis of the host response to hepatitis C virus infection.

Andrew I Su1, John P Pezacki, Lisa Wodicka, Amy D Brideau, Lubica Supekova, Robert Thimme, Stefan Wieland, Jens Bukh, Robert H Purcell, Peter G Schultz, Francis V Chisari.   

Abstract

We have examined the progression of hepatitis C virus (HCV) infections by gene expression analysis of liver biopsies in acutely infected chimpanzees that developed persistent infection, transient viral clearance, or sustained clearance. Both common responses and outcome-specific changes in expression were observed. All chimpanzees showed gene expression patterns consistent with an IFN-alpha response that correlated with the magnitude and duration of infection. Transient and sustained viral clearance were uniquely associated with induction of IFN-gamma-induced genes and other genes involved in antigen processing and presentation and the adaptive immune response. During the early stages of infection, host genes involved in lipid metabolism were also differentially regulated. We also show that drugs that affect these biosynthetic pathways can regulate HCV replication in HCV replicon systems. Our results reveal genome-wide transcriptional changes that reflect the establishment, spread, and control of infection, and they reveal potentially unique antiviral programs associated with clearance of HCV infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12441396      PMCID: PMC137774          DOI: 10.1073/pnas.202608199

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Regulated step in cholesterol feedback localized to budding of SCAP from ER membranes.

Authors:  A Nohturfft; D Yabe; J L Goldstein; M S Brown; P J Espenshade
Journal:  Cell       Date:  2000-08-04       Impact factor: 41.582

2.  Analysis of a successful immune response against hepatitis C virus.

Authors:  S Cooper; A L Erickson; E J Adams; J Kansopon; A J Weiner; D Y Chien; M Houghton; P Parham; C M Walker
Journal:  Immunity       Date:  1999-04       Impact factor: 31.745

3.  Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative transcriptional control.

Authors:  D E Levy; D S Kessler; R Pine; N Reich; J E Darnell
Journal:  Genes Dev       Date:  1988-04       Impact factor: 11.361

Review 4.  Cellular responses to interferon-gamma.

Authors:  U Boehm; T Klamp; M Groot; J C Howard
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

5.  Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees.

Authors:  X Forns; R Thimme; S Govindarajan; S U Emerson; R H Purcell; F V Chisari; J Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

6.  Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31.

Authors:  Y E Chang; L A Laimins
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

7.  Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5.

Authors:  P Hug; H M Lin; T Korte; X Xiao; D S Dimitrov; J M Wang; A Puri; R Blumenthal
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

8.  Experimental transmission of hepatitis C virus-associated fulminant hepatitis to a chimpanzee.

Authors:  P Farci; S J Munoz; A Shimoda; S Govindarajan; D C Wong; A Coiana; G Peddis; R Rubin; R H Purcell
Journal:  J Infect Dis       Date:  1999-04       Impact factor: 5.226

9.  Role of the vaccinia virus E3L and K3L gene products in rescue of VSV and EMCV from the effects of IFN-alpha.

Authors:  S T Shors; E Beattie; E Paoletti; J Tartaglia; B L Jacobs
Journal:  J Interferon Cytokine Res       Date:  1998-09       Impact factor: 2.607

10.  Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line.

Authors:  V Lohmann; F Körner; J Koch; U Herian; L Theilmann; R Bartenschlager
Journal:  Science       Date:  1999-07-02       Impact factor: 47.728

View more
  276 in total

1.  Activity-based protein profiling identifies a host enzyme, carboxylesterase 1, which is differentially active during hepatitis C virus replication.

Authors:  David R Blais; Rodney K Lyn; Michael A Joyce; Yanouchka Rouleau; Rineke Steenbergen; Nicola Barsby; Lin-Fu Zhu; Adrian F Pegoraro; Albert Stolow; David L Tyrrell; John Paul Pezacki
Journal:  J Biol Chem       Date:  2010-06-08       Impact factor: 5.157

2.  Severe insulin resistance in a treatment-naive chronic hepatitis C patient.

Authors:  Omar Khokhar; Jacqueline Fischer
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-08

3.  Plasmacytoid dendritic cells as guardians in hepatitis C virus-infected liver.

Authors:  Selena M Sagan; Peter Sarnow
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

4.  Sequence features that drive human promoter function and tissue specificity.

Authors:  Jane M Landolin; David S Johnson; Nathan D Trinklein; Shelly F Aldred; Catherine Medina; Hennady Shulha; Zhiping Weng; Richard M Myers
Journal:  Genome Res       Date:  2010-05-25       Impact factor: 9.043

Review 5.  Chemokines in the immunopathogenesis of hepatitis C infection.

Authors:  Mathis Heydtmann; David H Adams
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

6.  Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissiveness.

Authors:  Timothy Sheahan; Naoko Imanaka; Svetlana Marukian; Marcus Dorner; Peng Liu; Alexander Ploss; Charles M Rice
Journal:  Cell Host Microbe       Date:  2014-02-12       Impact factor: 21.023

7.  Limited hepatitis B virus replication space in the chronically hepatitis C virus-infected liver.

Authors:  S F Wieland; S Asabe; R E Engle; R H Purcell; F V Chisari
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

8.  Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies.

Authors:  Mohamed Hassan; Denis Selimovic; Abdelouahid El-Khattouti; Hanan Ghozlan; Youssef Haikel; Ola Abdelkader
Journal:  World J Exp Med       Date:  2012-04-20

Review 9.  Innate and Adaptive Immune Regulation During Chronic Viral Infections.

Authors:  Elina I Zuniga; Monica Macal; Gavin M Lewis; James A Harker
Journal:  Annu Rev Virol       Date:  2015-09-02       Impact factor: 10.431

Review 10.  Immune responses to HCV and other hepatitis viruses.

Authors:  Su-Hyung Park; Barbara Rehermann
Journal:  Immunity       Date:  2014-01-16       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.